NeoNeuro SAS has entered into a collaboration under the leadership of Professor Harald Hampel to work with the INSIGHT cohort for the application of the Aptamarker platform to pre-AD samples. The INSIGHT cohort is an innovative… NeoNeuro partners with the INSIGHT cohort
NeoNeuro SAS is pleased to announce a collaboration with the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) group. The collaboration is focused on exploring the potential of an innovative diagnostic platform developed… NeoNeuro collaborates with the AIBL study
NeoNeuro has received a new grant from BPIfrance Financement, CMI- Amorcage 2 to continue our research towards the development of aptamers as diagnostic and therapeutic tools for Alzheimer’s disease.
NeoNeuro has been granted support from BPIfrance Financement under the PIA-1 program for the use of aptamers as a diagnostic and therapeutic tools in Alzheimer’s disease.
